272 related articles for article (PubMed ID: 6237121)
1. Spinal fluid lymphocytes responsive to autologous and allogeneic cells in multiple sclerosis and control individuals.
Birnbaum G; Kotilinek L; Schwartz M; Sternad M
J Clin Invest; 1984 Oct; 74(4):1307-17. PubMed ID: 6237121
[TBL] [Abstract][Full Text] [Related]
2. Increased frequency of gamma delta T cells in cerebrospinal fluid and peripheral blood of patients with multiple sclerosis. Reactivity, cytotoxicity, and T cell receptor V gene rearrangements.
Stinissen P; Vandevyver C; Medaer R; Vandegaer L; Nies J; Tuyls L; Hafler DA; Raus J; Zhang J
J Immunol; 1995 May; 154(9):4883-94. PubMed ID: 7722338
[TBL] [Abstract][Full Text] [Related]
3. Multiple sclerosis: activated cells in cerebrospinal fluid in acute exacerbations.
Noronha A; Richman DP; Arnason BG
Ann Neurol; 1985 Dec; 18(6):722-5. PubMed ID: 3841270
[TBL] [Abstract][Full Text] [Related]
4. Spinal fluid lymphocytes from a subgroup of multiple sclerosis patients respond to mycobacterial antigens.
Birnbaum G; Kotilinek L; Albrecht L
Ann Neurol; 1993 Jul; 34(1):18-24. PubMed ID: 8517675
[TBL] [Abstract][Full Text] [Related]
5. Adhesion molecule expression on cerebrospinal fluid T lymphocytes: evidence for common recruitment mechanisms in multiple sclerosis, aseptic meningitis, and normal controls.
Svenningsson A; Hansson GK; Andersen O; Andersson R; Patarroyo M; Stemme S
Ann Neurol; 1993 Aug; 34(2):155-61. PubMed ID: 8338339
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic and functional characterization of T cell clones derived from the cerebrospinal fluid of multiple sclerosis patients.
Santoli D; Defreitas EC; Sandberg-Wollheim M; Francis MK; Koprowski H
J Immunol; 1984 May; 132(5):2386-92. PubMed ID: 6609197
[TBL] [Abstract][Full Text] [Related]
7. Autologous lymphocyte proliferation in multiple sclerosis and the effect of intravenous ACTH.
Birnbaum G; Kotilinek L
Ann Neurol; 1981 May; 9(5):439-46. PubMed ID: 6267984
[TBL] [Abstract][Full Text] [Related]
8. Growth of antigen specific, HLA restricted T lymphocyte clones from cerebrospinal fluid.
Fleischer B; Bogdahn U
Clin Exp Immunol; 1983 Apr; 52(1):38-44. PubMed ID: 6190597
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic and functional analysis of T cells cloned directly from the blood and cerebrospinal fluid of patients with multiple sclerosis.
Hafler DA; Buchsbaum M; Johnson D; Weiner HL
Ann Neurol; 1985 Oct; 18(4):451-8. PubMed ID: 2416267
[TBL] [Abstract][Full Text] [Related]
10. Immune surveillance in multiple sclerosis patients treated with natalizumab.
Stüve O; Marra CM; Jerome KR; Cook L; Cravens PD; Cepok S; Frohman EM; Phillips JT; Arendt G; Hemmer B; Monson NL; Racke MK
Ann Neurol; 2006 May; 59(5):743-7. PubMed ID: 16634029
[TBL] [Abstract][Full Text] [Related]
11. [Phenotypic and functional characterization of cloned T-lymphocytes from cerebrospinal fluid of patients with multiple sclerosis].
Barnaba V; Benvenuto R; Buttinelli C; Salvetti M; Toma L; Fiori P
Riv Neurol; 1990; 60(5):183-5. PubMed ID: 2100037
[TBL] [Abstract][Full Text] [Related]
12. Quantitation of T-cell receptor V beta chain expression on lymphocytes from blood, brain, and spinal fluid in patients with multiple sclerosis and other neurological diseases.
Birnbaum G; van Ness B
Ann Neurol; 1992 Jul; 32(1):24-30. PubMed ID: 1386501
[TBL] [Abstract][Full Text] [Related]
13. IgM, IgA and IgG producing cells in cerebrospinal fluid and peripheral blood in multiple sclerosis.
Henriksson A; Kam-Hansen S; Link H
Clin Exp Immunol; 1985 Oct; 62(1):176-84. PubMed ID: 4064372
[TBL] [Abstract][Full Text] [Related]
14. In vivo activated T lymphocytes in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis.
Hafler DA; Fox DA; Manning ME; Schlossman SF; Reinherz EL; Weiner HL
N Engl J Med; 1985 May; 312(22):1405-11. PubMed ID: 2985995
[TBL] [Abstract][Full Text] [Related]
15. The distribution of interleukin-2 receptor bearing lymphocytes in multiple sclerosis: evidence for a key role of activated lymphocytes.
Bellamy AS; Calder VL; Feldmann M; Davison AN
Clin Exp Immunol; 1985 Aug; 61(2):248-56. PubMed ID: 3930109
[TBL] [Abstract][Full Text] [Related]
16. Altered CD4+/CD8+ T-cell ratios in cerebrospinal fluid of natalizumab-treated patients with multiple sclerosis.
Stüve O; Marra CM; Bar-Or A; Niino M; Cravens PD; Cepok S; Frohman EM; Phillips JT; Arendt G; Jerome KR; Cook L; Grand'Maison F; Hemmer B; Monson NL; Racke MK
Arch Neurol; 2006 Oct; 63(10):1383-7. PubMed ID: 17030653
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid T cell clones from patients with multiple sclerosis: recognition of idiotopes on monoclonal IgG secreted by autologous cerebrospinal fluid B cells.
Holmøy T; Fredriksen AB; Thompson KM; Hestvik AL; Bogen B; Vartdal F
Eur J Immunol; 2005 Jun; 35(6):1786-94. PubMed ID: 15864781
[TBL] [Abstract][Full Text] [Related]
18. [Autologous mixed lymphocyte culture (AMLC)].
Volk HD; Grunow R
Allerg Immunol (Leipz); 1984; 30(2):60-73. PubMed ID: 6237558
[TBL] [Abstract][Full Text] [Related]
19. Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis.
Brucklacher-Waldert V; Stuerner K; Kolster M; Wolthausen J; Tolosa E
Brain; 2009 Dec; 132(Pt 12):3329-41. PubMed ID: 19933767
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid T cell responses against glutamic acid decarboxylase 65 in patients with stiff person syndrome.
Skorstad G; Hestvik AL; Vartdal F; Holmøy T
J Autoimmun; 2009 Feb; 32(1):24-32. PubMed ID: 19027267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
